查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402930

细胞检测市场：2024-2034

Cell-Based Assays Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 314 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2034 年，全球细胞检测市场规模将以 8.7% 的复合年增长率成长。

生物技术的进步，特别是基因组学、蛋白质组学和细胞生物学的进步，在推动对先进细胞检测的需求方面发挥关键作用。这些技术进步的融合为研究人员开闢了新的途径，使他们能够更深入地研究细胞功能、讯号传导途径和复杂分子相互作用的复杂性。例如，生技将在2023年为医药收入贡献3,040亿美元，近年来呈现持续成长趋势。据预测，到2026年这数字预计将成长至5,050亿美元。相比之下，同年传统药物市场预计价值 6,810 亿美元。此外，全球生物技术领域在肿瘤学领域也有所扩大，占率高达 39% 左右。这表明人们对癌症治疗和药物进步的关注和投资。

随着高通量定序技术的出现，基因组学领域取得了显着的进步，使研究人员能够以前所未有的速度和精度分析整个基因组。这种丰富的遗传资讯对于了解疾病的分子基础和识别潜在的治疗标靶至关重要。与基因组学一起，基于细胞的检测利用这些遗传知识来研究特定基因和突变如何影响细胞功能，为更有针对性和个性化的药物开发策略铺平道路。

本报告调查了全球细胞分析市场，并提供了市场概况、影响市场成长和市场机会的因素分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局和主要市场机会。公司简介等

目录

第一章 报告概述

第二章执行摘要

第 3 章市场概况

  • 主要发现
  • 市场动态
    • 市场驱动力
    • 市场限制
    • 市场机会
  • COVID-19 影响分析
  • 波特五力分析
  • PEST分析

第 4 章基于细胞的检测市场分析：按产品

  • 主要发现
  • 市场吸引力指数
  • 市场规模趋势和预测
  • 机器
    • 微孔板
    • □标仪
    • 液体处理系统
    • 孵化器
    • 显微镜
    • 其他
  • 消耗品
    • 试剂
    • 检测试剂盒
    • 细胞系
    • 探针标籤
    • 其他
  • 软件
  • 服务
    • 市场规模趋势与预测：按地区
    • 市占率：按地区

第五章基于细胞的检测市场分析：按应用

  • 主要发现
  • 市场吸引力指数
  • 市场规模趋势和预测
  • 药物发现
  • 基础调查
  • ADME研究
  • 毒理学
  • 其他
    • 市场规模趋势与预测：按地区
    • 市占率：按地区

第六章基于细胞的检测市场分析：按最终用户

  • 主要发现
  • 市场吸引力指数
  • 市场规模趋势和预测
  • 製药和生物技术公司
  • 学术机构
  • 合约研究组织
  • 其他
    • 市场规模趋势与预测：按地区
    • 市占率：按地区

第七章基于细胞的检测市场分析：按地区

  • 主要发现
  • 市场规模趋势和预测

第八章北美细胞检测市场分析

第九章欧洲细胞检测市场分析

第10章亚太地区细胞检测市场分析

第十一章拉丁美洲细胞检测市场分析

第十二章中东与非洲细胞检测市场分析

第十三章公司简介

  • 竞争格局
  • 战略视角
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioVision Inc.
  • Charles River Laboratories
  • Cisbio (Revvity)
  • Danaher Corporation
  • DiscoverX (Eurofins)
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare
  • InSphero
  • Merck KGaA
  • BioAgilytix Labs LLC
  • Thermo Fisher Scientific Inc.

第 14 章 一般评论/建议

  • Visiongain 的一般讨论
  • 对参与企业的建议
Product Code: PHA1307

The global Cell-Based Assays market is projected to grow at a CAGR of 8.7% by 2034 .

“The Cell-Based Assays Market Report 2024-2034”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Biotechnology Industry Projected to Boost Industry Growth

Advances in biotechnology, specifically in genomics, proteomics, and cell biology, are playing a pivotal role in propelling the demand for sophisticated cell-based assays. The convergence of these technological advancements has opened new avenues for researchers, enabling them to delve deeper into the intricacies of cellular functions, signaling pathways, and complex molecular interactions. For instance, in 2023, biotechnology contributed $304 billion to drug revenues, demonstrating a consistent upward trend over recent years. Projections indicate that this figure is anticipated to climb to $505 billion by 2026. In comparison, the conventional drug market is expected to reach a value of $681 billion in the same year. In addition, the global biotechnology sector experienced the prevalence of oncology, holding a significant share of around 39%. This highlights the substantial attention and investment directed toward the advancement of cancer treatments and therapies.

The field of genomics has witnessed remarkable progress with the advent of high-throughput sequencing technologies, allowing researchers to analyze entire genomes with unprecedented speed and precision. This wealth of genetic information has provided a foundation for understanding the molecular basis of diseases and identifying potential therapeutic targets. In tandem with genomics, cell-based assays capitalize on this genetic knowledge to study how specific genes and mutations influence cellular functions, paving the way for more targeted and personalized drug development strategies.

High Cost Associated with Cell-Based Assays Likely to Challenge Industry Growth

The development and deployment of sophisticated cell-based assays impose a considerable financial burden, acting as a formidable barrier for smaller research institutions and laboratories grappling with limited budgets. The principal contributors to these substantial upfront costs encompass the acquisition of advanced equipment, specialized reagents, and the maintenance of skilled personnel for assay design and execution. State-of-the-art technologies, such as high-content imaging systems and automated liquid handling platforms, come with hefty price tags, making them financially daunting for smaller institutions. The demand for specialized reagents, tailored to the intricacies of sophisticated assays, further escalates overall costs.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Cell-Based Assays market evolving?
  • What is driving and restraining the Cell-Based Assays market?
  • How will each Cell-Based Assays submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each Cell-Based Assays submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading Cell-Based Assays markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Cell-Based Assays projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of Cell-Based Assays projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Cell-Based Assays market?
  • Where is the Cell-Based Assays market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Cell-Based Assays market today, and over the next 10 years:

  • Our 314-page report provides 114 tables and 170 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Cell-Based Assays market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Cell-Based Assays prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product

  • Instruments
    • Microplates
    • Microplate Reader
    • Liquid Handling System
    • Incubator
    • Microscope
    • Others
  • Consumables
    • Reagents
    • Assay Kits
    • Cell Lines
    • Probes & Labels
    • Others
  • Software
  • Services

Application

  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Toxicology
  • Others

End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • CROs
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Cell-Based Assays Market 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

  • Agilent Technologies Inc
  • Becton, Dickinson and Company
  • BioAgilytix Labs LLC
  • Bio-Rad Laboratories
  • BioVision Inc
  • Charles River Laboratories
  • Cisbio (Revvity)
  • Danaher Corporation
  • DiscoverX (Eurofins)
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare
  • InSphero
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

Overall world revenue for Cell-Based Assays Market, 2024 to 2034 in terms of value the market will surpass US$18,800 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cell-Based Assays Market, 2024 to 2034 report help you?

In summary, our 310+ page report provides you with the following knowledge:

  • Revenue forecasts to 2034 for Cell-Based Assays Market, 2024 to 2034 Market, with forecasts for product, application and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 24 key national markets - See forecasts for the Cell-Based Assays Market 2024 to 2034 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Cell-Based Assays Market 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cell-Based Assays Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Cell-Based Assays Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increased Need of Cell-Based Assays in Drug Discovery and Development
      • 3.2.1.2 Advances in Biotechnology
      • 3.2.1.3 Growing Demand for Precision Medicine Impacting the Cell-Based Assays Market Positively
      • 3.2.1.4 Increasing Funding for Cell-based Research
      • 3.2.1.5 Rising Prevalence of Chronic Diseases
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 High Cost Associated with Cell-Based Assays
      • 3.2.2.2 Technical Complexity of Cell-Based Assays
      • 3.2.2.3 Lack of Standardization
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Growing Adoption of Label-Free Cell-Based Assays
      • 3.2.3.2 3D Cell Culture Models as a Cornerstone of Advanced Assays
      • 3.2.3.3 High-Throughput Screening Driving Demand for Cell-Based Assays
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Cell-Based Assays Market Analysis by Product

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Cell-Based Assays Market Size Estimation and Forecast by Product
  • 4.4 Instruments
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.3 Microplates
      • 4.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.4.3.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.4 Microplate Reader
      • 4.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.5 Liquid Handling System
      • 4.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.4.5.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.6 Incubator
      • 4.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.4.6.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.7 Microscope
      • 4.4.7.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.4.7.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.8 Others
      • 4.4.8.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Consumables
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.3 Reagents
      • 4.5.3.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.5.3.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.4 Assay Kits
      • 4.5.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.5.4.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.5 Cell Lines
      • 4.5.5.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.5.5.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.6 Probes & Labels
      • 4.5.6.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.5.6.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.7 Others
      • 4.5.7.1 Market Size by Region, 2024-2034 (US$ Million)
      • 4.5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Software
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Services
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Cell-Based Assays Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Cell-Based Assays Market Size Estimation and Forecast by Application
  • 5.4 Drug Discovery
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Basic Research
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 ADME Studies
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Toxicology
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Cell-Based Assays Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Cell-Based Assays Market Size Estimation and Forecast by End-users
  • 6.4 Pharmaceutical & Biotechnology Companies
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Academic Institutes
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 CROs
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Others
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Cell-Based Assays Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Cell-Based Assays Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Cell-Based Assays Market Attractiveness Index
  • 8.3 North America Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 8.4 North America Cell-Based Assays Market Size Estimation and Forecast by Country
  • 8.5 North America Cell-Based Assays Market Size Estimation and Forecast by Product
  • 8.6 North America Cell-Based Assays Market Size Estimation and Forecast by Application
  • 8.7 North America Cell-Based Assays Market Size Estimation and Forecast by End-users
  • 8.8 U.S. Cell-Based Assays Market Analysis
  • 8.9 Canada Cell-Based Assays Market Analysis

9 Europe Cell-Based Assays Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Cell-Based Assays Market Attractiveness Index
  • 9.3 Europe Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 9.4 Europe Cell-Based Assays Market Size Estimation and Forecast by Country
  • 9.5 Europe Cell-Based Assays Market Size Estimation and Forecast by Product
  • 9.6 Europe Cell-Based Assays Market Size Estimation and Forecast by Application
  • 9.7 Europe Cell-Based Assays Market Size Estimation and Forecast by End-users
  • 9.8 Germany Cell-Based Assays Market Analysis
  • 9.9 France Cell-Based Assays Market Analysis
  • 9.10 UK Cell-Based Assays Market Analysis
  • 9.11 Italy Cell-Based Assays Market Analysis
  • 9.12 Spain Cell-Based Assays Market Analysis
  • 9.13 Russia Cell-Based Assays Market Analysis
  • 9.14 Rest of Europe Cell-Based Assays Market Analysis

10 Asia Pacific Cell-Based Assays Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Cell-Based Assays Market Attractiveness Index
  • 10.3 Asia Pacific Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 Asia Pacific Cell-Based Assays Market Size Estimation .and Forecast by Country
  • 10.5 Asia Pacific Cell-Based Assays Market Size Estimation and Forecast by Product
  • 10.6 Asia Pacific Cell-Based Assays Market Size Estimation and Forecast by Application
  • 10.7 Asia Pacific Cell-Based Assays Market Size Estimation and Forecast by End-users
  • 10.8 Japan Cell-Based Assays Market Analysis
  • 10.9 China Cell-Based Assays Market Analysis
  • 10.10 India Cell-Based Assays Market Analysis
  • 10.11 Australia Cell-Based Assays Market Analysis
  • 10.12 South Korea Cell-Based Assays Market Analysis
  • 10.13 Singapore Cell-Based Assays Market Analysis
  • 10.14 Rest of Asia Pacific Cell-Based Assays Market Analysis

11 Latin America Cell-Based Assays Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Cell-Based Assays Market Attractiveness Index
  • 11.3 Latin America Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 Latin America Cell-Based Assays Market Size .Estimation and Forecast by Country
  • 11.5 Latin America Cell-Based Assays Market Size Estimation and Forecast by Product
  • 11.6 Latin America Cell-Based Assays Market Size Estimation and Forecast by Application
  • 11.7 Latin America Cell-Based Assays Market Size Estimation and Forecast by End-users
  • 11.8 Brazil Cell-Based Assays Market Analysis
  • 11.9 Mexico Cell-Based Assays Market Analysis
  • 11.10 Argentina Cell-Based Assays Market Analysis
  • 11.11 Colombia Cell-Based Assays Market Analysis
  • 11.12 Rest of Latin America Cell-Based Assays Market Analysis

12 MEA Cell-Based Assays Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Cell-Based Assays Market Attractiveness Index
  • 12.3 MEA Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 MEA Cell-Based Assays Market Size Estimation and Forecast by Country
  • 12.5 MEA Cell-Based Assays Market Size Estimation and Forecast by Product
  • 12.6 MEA Cell-Based Assays Market Size Estimation and Forecast by Application
  • 12.7 MEA Cell-Based Assays Market Size Estimation and Forecast by End-users
  • 12.8 GCC Cell-Based Assays Market Analysis
  • 12.9 South Africa Cell-Based Assays Market Analysis
  • 12.10 Rest of MEA Cell-Based Assays Market Analysis

13 Company Profiles

  • 13.1 Competitive Landscape, 2022
  • 13.2 Strategic Outlook
  • 13.3 Agilent Technologies, Inc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2017-2022
      • 13.3.3.2 Regional Market Shares, 2022
      • 13.3.3.3 R&D, 2017-2022
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Becton, Dickinson and Company
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2017-2022
      • 13.4.3.2 R&D, 2017-2022
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 Bio-Rad Laboratories, Inc.
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2017-2022
      • 13.5.3.2 Regional Market Share, 2022
      • 13.5.3.3 R&D, 2017-2022
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 BioVision Inc.
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Product Benchmarking
  • 13.7 Charles River Laboratories
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2017-2022
      • 13.7.3.2 Regional Market Share, 2022
    • 13.7.4 Product Benchmarking
  • 13.8 Cisbio (Revvity)
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Product Benchmarking
    • 13.8.4 Strategic Outlook
  • 13.9 Danaher Corporation
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2017-2022
      • 13.9.3.2 Regional Market Share, 2022
      • 13.9.3.3 R&D, 2017-2022
    • 13.9.4 Product Benchmarking
    • 13.9.5 Strategic Outlook
  • 13.10 DiscoverX (Eurofins)
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Product Benchmarking
    • 13.10.4 Strategic Outlook
  • 13.11 F. Hoffmann-La Roche Ltd
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
      • 13.11.3.1 Net Revenue, 2017-2022
      • 13.11.3.2 R&D, 2017-2022
    • 13.11.4 Product Benchmarking
    • 13.11.5 Strategic Outlook
  • 13.12 GE HealthCare
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Net Revenue, 2017-2022
      • 13.12.3.2 Regional Market Share, 2022
      • 13.12.3.3 R&D, 2017-2022
    • 13.12.4 Product Benchmarking
    • 13.12.5 Strategic Outlook
  • 13.13 InSphero
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Product Benchmarking
  • 13.14 Merck KGaA
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis
      • 13.14.3.1 Net Revenue, 2017-2022
      • 13.14.3.2 Regional Market Share, 2022
      • 13.14.3.3 R&D, 2017-2022
    • 13.14.4 Product Benchmarking
  • 13.15 BioAgilytix Labs LLC
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Product Benchmarking
  • 13.16 Thermo Fisher Scientific Inc.
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Financial Analysis
      • 13.16.3.1 Net Revenue, 2017-2022
      • 13.16.3.2 Regional Market Share, 2022
      • 13.16.3.3 R&D, 2017-2022
    • 13.16.4 Product Benchmarking

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players

List of Tables

  • Table 1 Cell-Based Assays Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Cell-Based Assays Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Cell-Based Assays Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Cell-Based Assays Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Cell-Based Assays Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 7 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 Microplates Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 Microplate Reader Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 Liquid Handling System Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Incubator Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Microscope Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Reagents Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Assay Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Probes & Labels Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Drug Discovery Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Basic Research Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 ADME Studies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 26 Toxicology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 30 Academic Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 CROs Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 Cell-Based Assays Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 North America Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 North America Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 North America Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 North America Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 U.S. Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 Canada Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Europe Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Europe Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 Europe Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Europe Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 Germany Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 France Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 UK Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 47 Italy Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Spain Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Russia Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 Rest of Europe Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 Asia Pacific Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Asia Pacific Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 Asia Pacific Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 Asia Pacific Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Japan Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 China Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 India Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Australia Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 South Korea Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Singapore Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 Rest of Asia Pacific Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Latin America Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 Latin America Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 Latin America Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Latin America Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 66 Brazil Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 Mexico Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 Argentina Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 Colombia Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 Rest of Latin America Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 MEA Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 MEA Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 73 MEA Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 MEA Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 75 GCC Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 76 South Africa Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 77 Rest of MEA Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 78 Strategic Outlook
  • Table 79 Agilent Technologies, Inc: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 80 Agilent Technologies, Inc: Product Benchmarking
  • Table 81 Agilent Technologies, Inc: Strategic Outlook
  • Table 82 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 83 Becton, Dickinson and Company: Product Benchmarking
  • Table 84 Becton, Dickinson and Company: Strategic Outlook
  • Table 85 Bio-Rad Laboratories, Inc: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 86 Bio-Rad Laboratories, Inc: Product Benchmarking
  • Table 87 Bio-Rad Laboratories, Inc: Strategic Outlook
  • Table 88 BioVision Inc: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 89 BioVision Inc: Product Benchmarking
  • Table 90 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 91 Charles River Laboratories: Product Benchmarking
  • Table 92 Cisbio (Revvity): Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 93 Cisbio (Revvity): Product Benchmarking
  • Table 94 Cisbio (Revvity): Strategic Outlook
  • Table 95 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 96 Danaher Corporation: Product Benchmarking
  • Table 97 Danaher Corporation: Strategic Outlook
  • Table 98 DiscoverX (Eurofins): Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 99 DiscoverX (Eurofins): Product Benchmarking
  • Table 100 DiscoverX (Eurofins): Strategic Outlook
  • Table 101 F Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 102 F Hoffmann-La Roche Ltd: Product Benchmarking
  • Table 103 F Hoffmann-La Roche Ltd: Strategic Outlook
  • Table 104 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 105 GE HealthCare: Product Benchmarking
  • Table 106 GE HealthCare: Strategic Outlook
  • Table 107 InSphero: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 108 InSphero: Product Benchmarking
  • Table 109 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 110 Merck KGaA: Product Benchmarking
  • Table 111 BioAgilytix Labs LLC: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 112 BioAgilytix Labs LLC: Product Benchmarking
  • Table 113 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No of Employees, Company Type, Website, Business Segment)
  • Table 114 Thermo Fisher Scientific Inc: Product Benchmarking

List of Figures

  • Figure 1 Cell-Based Assays Market Segmentation
  • Figure 2 Cell-Based Assays Market by Product: Market Attractiveness Index
  • Figure 3 Cell-Based Assays Market by Application: Market Attractiveness Index
  • Figure 4 Cell-Based Assays Market by End-users: Market Attractiveness Index
  • Figure 5 Cell-Based Assays Market Attractiveness Index by Region
  • Figure 6 Cell-Based Assays Market: Market Dynamics
  • Figure 7 Cell-Based Assays Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 8 Cell-Based Assays Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 9 Cell-Based Assays Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 10 Cell-Based Assays Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 11 Cell-Based Assays Market: Porter's Five Forces Analysis
  • Figure 12 Cell-Based Assays Market: PEST Analysis
  • Figure 13 Cell-Based Assays Market by Product: Market Attractiveness Index
  • Figure 14 Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 15 Cell-Based Assays Market Share Forecast by Product, 2023, 2028, 2033 (%)
  • Figure 16 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 17 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 18 Microplates Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 19 Microplates Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 Microplate Reader Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 21 Microplate Reader Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Liquid Handling System Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 23 Liquid Handling System Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Incubator Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 25 Incubator Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 26 Microscope Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 27 Microscope Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 28 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 29 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 31 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 Reagents Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 33 Reagents Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Assay Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 35 Assay Kits Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 37 Cell Lines Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Probes & Labels Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 39 Probes & Labels Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 40 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 41 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 42 Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 43 Software Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 44 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 45 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 46 Cell-Based Assays Market by Application: Market Attractiveness Index
  • Figure 47 Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 48 Cell-Based Assays Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 49 Drug Discovery Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 50 Drug Discovery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 51 Basic Research Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 52 Basic Research Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 53 ADME Studies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 54 ADME Studies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 55 Toxicology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 56 Toxicology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 57 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 58 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 59 Cell-Based Assays Market by End-users: Market Attractiveness Index
  • Figure 60 Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 61 Cell-Based Assays Market Share Forecast by End-users, 2023, 2028, 2033 (%)
  • Figure 62 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 63 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 64 Academic Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 65 Academic Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 66 CROs Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 67 CROs Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 68 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 69 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 70 Cell-Based Assays Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
  • Figure 71 Cell-Based Assays Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 72 Cell-Based Assays Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 73 North America Cell-Based Assays Market Attractiveness Index
  • Figure 74 North America Cell-Based Assays Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 75 North America Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 76 North America Cell-Based Assays Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 77 North America Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 78 North America Cell-Based Assays Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 79 North America Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 80 North America Cell-Based Assays Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 81 North America Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 82 North America Cell-Based Assays Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 83 U.S. Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 84 Canada Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 85 Europe Cell-Based Assays Market Attractiveness Index
  • Figure 86 Europe Cell-Based Assays Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 87 Europe Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 88 Europe Cell-Based Assays Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 89 Europe Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 90 Europe Cell-Based Assays Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 91 Europe Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 92 Europe Cell-Based Assays Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 93 Europe Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 94 Europe Cell-Based Assays Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 95 Germany Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 96 France Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 97 UK Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 98 Italy Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 99 Spain Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 100 Russia Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Rest of Europe Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 102 Asia Pacific Cell-Based Assays Market Attractiveness Index
  • Figure 103 Asia Pacific Cell-Based Assays Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 104 Asia Pacific Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 105 Asia Pacific Cell-Based Assays Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 106 Asia Pacific Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 107 Asia Pacific Cell-Based Assays Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 108 Asia Pacific Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 109 Asia Pacific Cell-Based Assays Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 110 Asia Pacific Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 111 Asia Pacific Cell-Based Assays Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 112 Japan Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 113 China Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 114 India Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 115 Australia Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 116 South Korea Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 117 Singapore Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 118 Rest of Asia Pacific Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 119 Latin America Cell-Based Assays Market Attractiveness Index
  • Figure 120 Latin America Cell-Based Assays Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 121 Latin America Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 122 Latin America Cell-Based Assays Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 123 Latin America Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 124 Latin America Cell-Based Assays Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 125 Latin America Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 126 Latin America Cell-Based Assays Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 127 Latin America Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 128 Latin America Cell-Based Assays Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 129 Brazil Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 130 Mexico Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 131 Argentina Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 132 Colombia Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 133 Rest of Latin America Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 134 MEA Cell-Based Assays Market Attractiveness Index
  • Figure 135 MEA Cell-Based Assays Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 136 MEA Cell-Based Assays Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 137 MEA Cell-Based Assays Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 138 MEA Cell-Based Assays Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 139 MEA Cell-Based Assays Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 140 MEA Cell-Based Assays Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 141 MEA Cell-Based Assays Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 142 MEA Cell-Based Assays Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 143 MEA Cell-Based Assays Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 144 GCC Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 145 South Africa Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 146 Rest of MEA Cell-Based Assays Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 147 Agilent Technologies, Inc: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 148 Agilent Technologies, Inc: Regional Market Shares, 2022
  • Figure 149 Agilent Technologies, Inc: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 150 Becton, Dickinson and Company: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 151 Becton, Dickinson and Company: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 152 Bio-Rad Laboratories, Inc: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 153 Bio-Rad Laboratories, Inc: Regional Market Share, 2022
  • Figure 154 Bio-Rad Laboratories, Inc: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 155 Charles River Laboratories: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 156 Charles River Laboratories: Regional Market Share, 2022
  • Figure 157 Danaher Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 158 Danaher Corporation: Regional Market Share, 2022
  • Figure 159 Danaher Corporation: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 160 F Hoffmann-La Roche Ltd: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 161 F Hoffmann-La Roche Ltd: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 162 GE HealthCare: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 163 GE HealthCare: Regional Market Share, 2022
  • Figure 164 GE HealthCare: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 165 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 166 Merck KGaA: Regional Market Share, 2022
  • Figure 167 Merck KGaA: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 168 Thermo Fisher Scientific Inc: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 169 Thermo Fisher Scientific Inc: Regional Market Share, 2022
  • Figure 170 Thermo Fisher Scientific Inc: R&D, 2017-2022 (US$ Million, AGR %)